EZH2 and central nervous system cancer: The results showed that EZH2 expression affected DFI in patients with glioma (GBMLGG), pan-kidney cohort (KIPAN), LGG, ACC, KICH, LIHC, MESO, PCPG, KIRP, KIRC, PRAD, UVM, PAAD, and SKCM-P (Supplementary Figure S4B).